The study of anti-obesity effect by recovery of endogenous oxytocin secretion and its clinical implication
Project/Area Number |
18K08483
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Review Section |
Basic Section 54040:Metabolism and endocrinology-related
|
Research Institution | Fukushima Medical University |
Principal Investigator |
Maejima Yuko 福島県立医科大学, 医学部, 准教授 (40438669)
|
Co-Investigator(Kenkyū-buntansha) |
下村 健寿 福島県立医科大学, 医学部, 教授 (90636226)
|
Project Period (FY) |
2018-04-01 – 2021-03-31
|
Project Status |
Completed (Fiscal Year 2020)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2018: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
Keywords | オキシトシン / 肥満 / GLP-1 / 食欲 / マウス / メタボリックシンドローム |
Outline of Final Research Achievements |
It has been reported that neuropeptide oxytocin (Oxt) has anti-obesity effects. On the other hand, GLP-1 has already been approved as anti-obesity drug in US and Europe. The present study examined the effects of peripheral co-administration of Oxt and GLP-1 on the feeding and body weight in high fat diet induced obese mice. Co-administration of low dose Oxt and GLP-1 enhanced anti-obesity effects than single administration of Oxt and GLP-1, respectively. Co-administration of Oxt and GLP-1 stimulate neuronal activity in paraventricular nucleus (PVN), which is important for the anorexigenic effects. Enhanced anti-obesity effects induced by Oxt and GLP-1 may mediate neuronal activity in the PVN.
|
Academic Significance and Societal Importance of the Research Achievements |
本研究は抗肥満効果のあることが知られている2種類のホルモン、オキシトシンとGLP-1の共投与が肥満マウスを効率よく体重減少させるかを調べ、それぞれ単独よりも抗肥満効果が増強されることを明らかにした。近年、複数の成分を組み合わせることで、単剤よりも高い効果や安全性という観点から「合剤」が注目されているが、本研究では低用量オキシトシンとGLP-1を組み合わせることでより高い食欲抑制・抗肥満効果を明らかにした。現在安全な抗肥満薬が存在しない中、本研究で明らかになったオキシトシンとGLP-1の組み合わせにより高い抗肥満効果が得られることは、臨床応用という観点からも非常に有意義な成果であると考えられる。
|
Report
(2 results)
Research Products
(9 results)
-
-
-
-
-
-
[Journal Article] Gs/Gq signaling switch in β cells defines incretin effectiveness in diabetes2020
Author(s)
Oduori Okechi S.、Murao Naoya、Shimomura Kenju、Takahashi Harumi、Zhang Quan、Dou Haiqiang、Sakai Shihomi、Minami Kohtaro、Chanclon Belen、Guida Claudia、Kothegala Lakshmi、Tol? Johan、Maejima Yuko、Yokoi Norihide、Minami Yasuhiro、Miki Takashi、Rorsman Patrik、Seino Susumu
-
Journal Title
Journal of Clinical Investigation
Volume: 130
Issue: 12
Pages: 6639-6655
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-